SEC Form 4 research
| Issuer | Beam Therapeutics Inc. |
|---|---|
| Tickers | BEAM |
| Reporting owners | 27 |
| Officers and directors | 7 |
| Last public filing | 2026-10-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-16 | Evans John M. | S | 25,000 | $23.98 | Not reported |
| 2026-10-16 | 2026-10-15 | Evans John M. | S | 25,000 | $23.57 | Not reported |
| 2026-10-02 | 2026-10-01 | Cavanagh Bethany J | S | 187 | $24.41 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.